156 related articles for article (PubMed ID: 8890230)
1. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis.
Fratti RA; Ghannoum MA; Edwards JE; Filler SG
Infect Immun; 1996 Nov; 64(11):4714-8. PubMed ID: 8890230
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell injury caused by Candida albicans is dependent on iron.
Fratti RA; Belanger PH; Ghannoum MA; Edwards JE; Filler SG
Infect Immun; 1998 Jan; 66(1):191-6. PubMed ID: 9423857
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma protects endothelial cells from damage by Candida albicans.
Ibrahim AS; Filler SG; Ghannoum MA; Edwards JE
J Infect Dis; 1993 Jun; 167(6):1467-70. PubMed ID: 8501342
[TBL] [Abstract][Full Text] [Related]
4. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells.
Filler SG; Pfunder AS; Spellberg BJ; Spellberg JP; Edwards JE
Infect Immun; 1996 Jul; 64(7):2609-17. PubMed ID: 8698486
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma activates the oxidative killing of Candida albicans by human granulocytes.
Stevenhagen A; van Furth R
Clin Exp Immunol; 1993 Jan; 91(1):170-5. PubMed ID: 8419079
[TBL] [Abstract][Full Text] [Related]
6. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon.
Brummer E; Stevens DA
J Med Microbiol; 1989 Mar; 28(3):173-81. PubMed ID: 2494342
[TBL] [Abstract][Full Text] [Related]
7. Penetration and damage of endothelial cells by Candida albicans.
Filler SG; Swerdloff JN; Hobbs C; Luckett PM
Infect Immun; 1995 Mar; 63(3):976-83. PubMed ID: 7868270
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans stimulates endothelial cell eicosanoid production.
Filler SG; Ibe BO; Luckett PM; Raj JU; Edwards JE
J Infect Dis; 1991 Nov; 164(5):928-35. PubMed ID: 1940471
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase.
Lefkowitz SS; Gelderman MP; Lefkowitz DL; Moguilevsky N; Bollen A
J Infect Dis; 1996 May; 173(5):1202-7. PubMed ID: 8627073
[TBL] [Abstract][Full Text] [Related]
10. A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.
Coste A; Linas MD; Cassaing S; Bernad J; Chalmeton S; Séguéla JP; Pipy B
J Antimicrob Chemother; 2002 May; 49(5):731-40. PubMed ID: 12003965
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
[TBL] [Abstract][Full Text] [Related]
12. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.
Ghannoum MA; Filler SG; Ibrahim AS; Fu Y; Edwards JE
Antimicrob Agents Chemother; 1992 Oct; 36(10):2239-44. PubMed ID: 1444305
[TBL] [Abstract][Full Text] [Related]
13. Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species.
Roilides E; Holmes A; Blake C; Pizzo PA; Walsh TJ
J Leukoc Biol; 1995 Apr; 57(4):651-6. PubMed ID: 7536791
[TBL] [Abstract][Full Text] [Related]
14. The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.
Fratti RA; Belanger PH; Sanati H; Ghannoum MA
J Chemother; 1998 Feb; 10(1):7-16. PubMed ID: 9531069
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection.
Orozco AS; Zhou X; Filler SG
Infect Immun; 2000 Mar; 68(3):1134-41. PubMed ID: 10678917
[TBL] [Abstract][Full Text] [Related]
16. Role of hyphal formation in interactions of Candida albicans with endothelial cells.
Phan QT; Belanger PH; Filler SG
Infect Immun; 2000 Jun; 68(6):3485-90. PubMed ID: 10816502
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants.
Grimm M; Spiecker M; De Caterina R; Shin WS; Liao JK
J Biol Chem; 2002 Jul; 277(29):26460-7. PubMed ID: 12006557
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment.
Marcil A; Harcus D; Thomas DY; Whiteway M
Infect Immun; 2002 Nov; 70(11):6319-29. PubMed ID: 12379711
[TBL] [Abstract][Full Text] [Related]
20. Protein-calorie malnutrition impairs host defense against Candida albicans.
Redmond HP; Shou J; Kelly CJ; Leon P; Daly JM
J Surg Res; 1991 Jun; 50(6):552-9. PubMed ID: 1646910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
